Titan Pharmaceuticals (TTNP) Competitors $3.68 -0.19 (-4.91%) Closing price 03:59 PM EasternExtended Trading$3.66 -0.03 (-0.68%) As of 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TTNP vs. IPA, IXHL, CTXR, IMNN, FLGC, BMRA, ATHA, APRE, TRIB, and MBRXShould you be buying Titan Pharmaceuticals stock or one of its competitors? The main competitors of Titan Pharmaceuticals include ImmunoPrecise Antibodies (IPA), Incannex Healthcare (IXHL), Citius Pharmaceuticals (CTXR), Imunon (IMNN), Flora Growth (FLGC), Biomerica (BMRA), Athira Pharma (ATHA), Aprea Therapeutics (APRE), Trinity Biotech (TRIB), and Moleculin Biotech (MBRX). These companies are all part of the "pharmaceutical products" industry. Titan Pharmaceuticals vs. ImmunoPrecise Antibodies Incannex Healthcare Citius Pharmaceuticals Imunon Flora Growth Biomerica Athira Pharma Aprea Therapeutics Trinity Biotech Moleculin Biotech ImmunoPrecise Antibodies (NASDAQ:IPA) and Titan Pharmaceuticals (NASDAQ:TTNP) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, community ranking, valuation, risk and institutional ownership. Do insiders and institutionals have more ownership in IPA or TTNP? 6.7% of ImmunoPrecise Antibodies shares are held by institutional investors. Comparatively, 31.5% of Titan Pharmaceuticals shares are held by institutional investors. 6.8% of ImmunoPrecise Antibodies shares are held by company insiders. Comparatively, 24.9% of Titan Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, IPA or TTNP? ImmunoPrecise Antibodies has a beta of 0.09, suggesting that its share price is 91% less volatile than the S&P 500. Comparatively, Titan Pharmaceuticals has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Is IPA or TTNP more profitable? Titan Pharmaceuticals has a net margin of 0.00% compared to ImmunoPrecise Antibodies' net margin of -114.50%. ImmunoPrecise Antibodies' return on equity of -73.74% beat Titan Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ImmunoPrecise Antibodies-114.50% -73.74% -42.68% Titan Pharmaceuticals N/A -118.01%-103.79% Does the MarketBeat Community prefer IPA or TTNP? Titan Pharmaceuticals received 323 more outperform votes than ImmunoPrecise Antibodies when rated by MarketBeat users. However, 92.31% of users gave ImmunoPrecise Antibodies an outperform vote while only 53.43% of users gave Titan Pharmaceuticals an outperform vote. CompanyUnderperformOutperformImmunoPrecise AntibodiesOutperform Votes1292.31% Underperform Votes17.69%Titan PharmaceuticalsOutperform Votes33553.43% Underperform Votes29246.57% Which has preferable earnings & valuation, IPA or TTNP? Titan Pharmaceuticals has lower revenue, but higher earnings than ImmunoPrecise Antibodies. Titan Pharmaceuticals is trading at a lower price-to-earnings ratio than ImmunoPrecise Antibodies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmunoPrecise Antibodies$24.07M0.50-$20.13M-$0.78-0.50Titan Pharmaceuticals$180K18.99-$5.57M-$5.21-0.72 Do analysts rate IPA or TTNP? ImmunoPrecise Antibodies currently has a consensus price target of $5.00, suggesting a potential upside of 1,178.77%. Given ImmunoPrecise Antibodies' stronger consensus rating and higher probable upside, analysts plainly believe ImmunoPrecise Antibodies is more favorable than Titan Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ImmunoPrecise Antibodies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Titan Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer IPA or TTNP? In the previous week, ImmunoPrecise Antibodies had 2 more articles in the media than Titan Pharmaceuticals. MarketBeat recorded 5 mentions for ImmunoPrecise Antibodies and 3 mentions for Titan Pharmaceuticals. Titan Pharmaceuticals' average media sentiment score of 0.96 beat ImmunoPrecise Antibodies' score of 0.29 indicating that Titan Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ImmunoPrecise Antibodies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Titan Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryImmunoPrecise Antibodies beats Titan Pharmaceuticals on 10 of the 18 factors compared between the two stocks. Remove Ads Get Titan Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TTNP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTNP vs. The Competition Export to ExcelMetricTitan PharmaceuticalsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.42M$3.02B$5.63B$7.83BDividend YieldN/A1.56%4.57%4.00%P/E Ratio-0.7228.8123.1218.67Price / Sales18.99426.82388.1791.15Price / CashN/A168.6838.1634.64Price / Book0.423.916.884.23Net Income-$5.57M-$71.95M$3.20B$247.15M7 Day Performance-10.74%-5.82%-2.86%-2.16%1 Month Performance-6.03%-12.20%1.72%-5.71%1 Year Performance-47.77%-28.67%9.77%-0.81% Titan Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTNPTitan Pharmaceuticals1.5805 of 5 stars$3.68-4.9%N/A-46.9%$3.36M$180,000.00-0.7110Upcoming EarningsAnalyst ForecastShort Interest ↓Gap DownIPAImmunoPrecise Antibodies2.2995 of 5 stars$0.43+11.5%$5.00+1,065.5%-72.0%$13.33M$24.07M-0.5580Earnings ReportShort Interest ↑News CoverageGap UpIXHLIncannex Healthcare0.9513 of 5 stars$0.74flatN/A-77.8%$13.22M$98,000.00-0.533Positive NewsCTXRCitius Pharmaceuticals3.3062 of 5 stars$1.53+2.0%$54.50+3,462.1%-93.7%$13.15MN/A0.0020Positive NewsIMNNImunon2.2712 of 5 stars$0.89+2.9%$20.50+2,203.4%-18.6%$13.01M$500,000.00-0.4730Analyst ForecastPositive NewsFLGCFlora Growth3.2395 of 5 stars$0.67+7.2%$5.00+651.9%-70.0%$12.93M$64.15M0.00280Earnings ReportShort Interest ↓BMRABiomerica0.9899 of 5 stars$0.70+12.6%N/A-30.4%$12.83M$5.58M-2.0660Short Interest ↓News CoveragePositive NewsATHAAthira Pharma2.5242 of 5 stars$0.33-2.5%$13.83+4,130.4%-88.2%$12.77MN/A-0.1140Positive NewsAPREAprea Therapeutics2.6827 of 5 stars$2.34-2.5%$15.50+562.4%-63.8%$12.72M$580,000.00-0.837Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionGap UpTRIBTrinity Biotech1.4998 of 5 stars$0.690.0%N/A-66.3%$12.37M$59.13M-0.30480Upcoming EarningsGap DownMBRXMoleculin Biotech2.9114 of 5 stars$1.13flat$18.67+1,551.9%-81.0%$12.27MN/A0.0020Analyst UpgradeShort Interest ↓Analyst RevisionNews Coverage Remove Ads Related Companies and Tools Related Companies ImmunoPrecise Antibodies Alternatives Incannex Healthcare Alternatives Citius Pharmaceuticals Alternatives Imunon Alternatives Flora Growth Alternatives Biomerica Alternatives Athira Pharma Alternatives Aprea Therapeutics Alternatives Trinity Biotech Alternatives Moleculin Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TTNP) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TTNP Stock Free TTNP Stock Alerts